share_log

一周新股 | 由李宁发起的SPAC递表,汇通达正在招股中

Weekly IPO | SPAC initiated by Li Ning submitted the form, and Huitongda is in the process of offering shares

富途資訊 ·  Feb 5, 2022 22:20

logo

This week, the Hang Seng Index rose 4.34% to close at 24573.29.

This week, a total of eight new shares were submitted to the main board of the Hong Kong Stock Exchange, one new share was announced, two new shares were listed, and no new shares were listed.

There are two special purpose buy-out companies this week, Trinity Acquisition is sponsored by Mr. Li Ning Co. Ltd., LionRock and Astrapto, targeting global consumer lifestyle companies based in China, and Interra Acquisition Corporation is sponsored by Chunhua and Agricultural Bank of China International Asset Management, which will focus on high-growth companies in the Greater China region.

In addition, VSPN, the world's largest e-sports operator, submitted to the Hong Kong Stock Exchange as the official professional e-sports event operator of "Arena of Valor", "Game for Peace" and "PUBG".

logo

There are a total of 8 IPOs this week.

Trinity AcquisitionFor a special purpose acquisition company (SPAC), targeting global consumer lifestyle companies located in China with strong growth potential and benefiting from the company's sponsors and management team. The sponsors of the company are Mr. Li Ning Co. Ltd., LionRock and Astrapto, who beneficially own 33%, 42% and 25% of all Class B shares issued, respectively.

The company's competitive advantages include a good track record in creating significant shareholder value; a unique combination of investment, operations and Chinese expertise; extensive network and industry relationships facilitate the search for proprietary business opportunities; be able to add significant value and promote value creation for potential special purpose acquisition company purchase targets.

VSPNIs an one-stop integrated service provider with e-sports as the core, e-sports content producer who covers fans all over the world. According to the Frost Sullivan report, VSPN ranked first in Asia in terms of the number of events held in 2020, while VSPN ranked first in China in terms of income from e-sports 's event business and commercialization. According to the "Baidu, Inc. Index" in 2020, VSPN covers nine of the ten most popular e-sports games in China, including "Arena of Valor" and "Game for Peace".

Bourne opticsIt is a provider of smart device appearance structure and module solution. According to Frost Sullivan, in 2020, the company ranked first in terms of shipping value among providers of smart device appearance structures and module solutions, with a market share of 17.6%. The company is one of the first companies to start planning and producing automotive glass for interior decoration and other new applications such as lidar and ARHUD.

Think more about cloud technologyMainly provides integrated marketing solution services in China, and is committed to becoming a technology platform enterprise for intelligent marketing. During the track record period, more than 200 customers hired Duoxian Cloud to provide integrated marketing solutions, which was particularly successful in the FMCG and footwear industries. Duoyun's customer brands include: Hongxing Erke, ABCKids, Han Hou, Li Bai, Fei Le, Jin Guan, 361o, Guiren Bird, Panpan, Heng an, Anjing, China Resources Land and Vanke.

Zhonglian ShippingIs a leading and fastest growing container shipping company in China. According to Alphaliner, as of January 24, 2022, the company was the second largest container shipping company headquartered in Chinese mainland and providing both offshore and ocean routes. From October 2, 2020 to January 24, 2022, the company's international capacity ranking rose from 95th to 22nd.

CallisonIs a biotech company dedicated to the development of perioperative new drugs based on the company's drug delivery platform and other patented technologies, with a view to extending its coverage to the production and commercialization of pharmaceutical products developed by the company. achieve end-to-end development capabilities. The company's product pipeline focuses on non-opioid postoperative pain management, anti-inflammatory pain control, anesthesia and sedation, in view of unmet medical needs.

Interra Acquisition CorporationThe sponsors, Primavera LLC, Agricultural Bank of China International Capital Management and ABCI AM Acquisition, will focus on high-growth companies in the Greater China region.

Primavera LLC has a joint shareholder with Chunhua, a well-known private equity group, and its holder is also the founder, partner and owner of Chunhua. As a leading alternative investment management company in China, Chunhua provides fund management services for top financial institutions, sovereign wealth funds, pension plans, endowment funds, enterprises and family offices; ABCI AM Acquisition is a special purpose company wholly owned by AgBank International Capital Management. AgBank International Asset Management (together with the domestic entities of Agricultural Bank of China International) has rich experience in investment transactions and currently manages more than 70 funds with a total subscription of more than 100 billion yuan.

Live a wise life in ZhonganHeadquartered in Hangzhou, deeply rooted in Zhejiang Province and the Yangtze River Delta region, and through the establishment of strategic distribution in cities outside the Yangtze River Delta region; the company has a total of 108 contract projects with a total contract floor area of about 171 million square meters, covering 17 cities and seven provinces in China; and managing a total of 74 projects with a total construction area of about 118 million square meters, covering six cities and two provinces in China.

logo

Lepu biologyIs a biopharmaceutical company focusing on the field of tumor treatment, the company has built a number of tumor product pipelines. As of the last practical date, the company has eight clinical stage drug candidates, three preclinical drug candidates and three clinical stage drug candidates in its product line. As of the latest practicable date, the company has initiated 28 clinical trials, of which three have entered the registration phase and two are under way in the United States.

logo

There are two new offerings this week.

$remittance access Network (09878.HK) $The company plans to issue 51.6062 million shares at an issue price of HK $43 to HK $48 each, which is expected to be listed on February 18. As of press time, the margin of Huitongda Network is not yet full, and the subscription amount of the margin has reached 25.54 million yuan.

$clear Medical (01406.HK) $A total of 136 million shares will be issued from January 31 to February 10 at an issue price of HK $1.60-3 per share, 1250 shares per share, and is expected to be listed on February 18. As of press time, it is clear that the medical margin is not yet full, and the margin subscription amounts to 18.74 million yuan.

Edit / Ceemon

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment